Penn Center for Innovation

Neuraly announces Strategic Sponsored Research Agreement with Penn

Posted on November 11, 2020 — Jessica Jones Gupta

Neuraly, Inc, a clinical-stage biotechnology company pioneering disease-modifying agents for neurodegenerative disorders, announced a strategic sponsored research agreement with the University of Pennsylvania to study the use of NLY01 to therapeutically target a neuroinflammatory mechanism of glaucoma.

Read the Press Release

Category: external, news